Value £47,513,268

Quanta Dialysis Technologies

VC Funding

Growth

Healthcare & Biotech Published 18 November 2024

Summary

In a significant market movement during November 2024, Quanta Dialysis Technologies was the subject of a vc funding. The transaction achieved a gross valuation of £47,513,268. Leading the round was b2venture, Novo Holdings, Glenview Capital.

This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.

Lead Investor / Acquirer

b2venture

Lead Investor / Acquirer

Novo Holdings

Lead Investor / Acquirer

Glenview Capital

Advising Broker

Undisclosed Firm

Related Deals in Healthcare & Biotech

Growth prioritised

VC Funding

Scan.com

£67,220,000

Sept 2026

VC Funding

Ternary Therapeutics

£3,600,000

Mar 2026

VC Funding

NuVision Biotherapies

£4,800,000

Mar 2026

VC Funding

Evaro

£18,000,000

Jan 2026

View Company Details

Financials, officers, full deal history

Original Source

This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.

View on Tech.eu Funding Explorer

Funding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.

AI Insight Lenses

Pro

AI-generated analysis from four professional perspectives. Powered by PE Deals.

Free to all registered users.